Cargando…

OR34-4 ATF3 Is A Converging Point For AR Signaling And Fatty Acid Oxidation In Prostate Cancer

Prostate cancer (PCa) is the second most prevalent cancer and leading causes of death among men worldwide. Androgen deprivation is the first line of treatment for locally advanced and metastatic PCa. For men who develop metastatic, castration-resistant PCa (CRPC), survival is limited. Thus, there is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joshi, Molishree, Salzmann-Sullivan, Maren, Schlaepfer, Isabel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Tumor Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555074/ http://dx.doi.org/10.1210/js.2019-OR34-4

Ejemplares similares

CPT1A Supports Castration-Resistant Prostate Cancer in Androgen-Deprived Conditions
por: Joshi, Molishree, et al.
Publicado: (2019)

RF27 | LBSUN342 Ar-targeted Linked-read Sequencing Reveals Complex Ar Structural Variants In Castration Resistant Prostate Cancer Models
por: Zivanovic, Andrej, et al.
Publicado: (2022)

THU496 A Positive Relationship Exists Between CARF And AR In Prostate Cancer
por: Hasan, Kamrul M, et al.
Publicado: (2023)

SAT633 The RNA Helicase UPF1 Mediates AR- And SRF-dependent Transcription In Prostate Cancer
por: Chauhan, Gaurav, et al.
Publicado: (2023)

OR34-3 The Androgen Receptor Malignancy Shift Can Be Caused by Mutations Commonly Found in Primary Prostate Cancer
por: Copeland, Ben, et al.
Publicado: (2019)

SAT-330 Preclinical Screen of Patient CRPC Tumors Shows Sensitivity to Bromodomain Inhibitors Includes AR-null and Neuroendocrine Disease
por: Risbridger, Gail, et al.
Publicado: (2019)

ATF3 Reprograms the Bone Marrow Niche in Response to Early Breast Cancer Transformation
por: Perrone, Milena, et al.
Publicado: (2023)

Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade
por: Flaig, Thomas W., et al.
Publicado: (2017)

OR34-1 Regulation of Breast Cancer Stem Cells by Nuclear Receptor Co-Regulatory Proteins
por: Ostrander, Julie, et al.
Publicado: (2019)

OR34-6 A Novel Mechanism of SDH-Deficient Tumorigenesis and Implications for Genetic Testing in Patients with Pheochromocytoma-Paraganglioma
por: De Sousa, Sunita M.C., et al.
Publicado: (2019)

OR34-5 Infiltrating Neutrophils and Neutrophil Elastase (NE) Promote Tumor Growth in a Mouse Model for Lymphangioleiomyomatosis (LAM)
por: Taya, Manisha, et al.
Publicado: (2019)

SUN-143 Prostatic Acid Phosphatase Is Not Regulated by Androgens During Prostate Development and Tumorigenesis
por: Izadmehr, Sudeh, et al.
Publicado: (2020)

OR34-2 SREBP1 Drives KRT80-Dependent Cytoskeletal Changes and Invasive Behaviour in Endocrine-Resistant ERα Breast Cancer
por: Perone, Ylenia, et al.
Publicado: (2019)

THU544 Prostatic Acid Phosphatase Is Negatively Regulated By Androgens And Persists In Castrate-resistant Metastatic Prostate Cancer
por: Rajagopalan, Vinodh, et al.
Publicado: (2023)

THU488 Genetic Alterations In CREBRF Influence Prostate Cancer Survival And Impact Prostate Tissue Homeostasis In Mice
por: Pascal, Laura E, et al.
Publicado: (2023)

ODP548 Fatty acid metabolism-related factors in breast and endometrial cancers
por: Miki, Yasuhiro, et al.
Publicado: (2022)

SAT-326 INPP4B Suppresses Prostate Inflammation And Protects Mice Fed With High-fat Diet From The Development Of Prostate Intraepithelial Neoplasia
por: Zhang, Manqi, et al.
Publicado: (2019)

SAT-328 Androgens Modulate the Expression of Prostatic Acid Phosphatase
por: Izadmehr, Sudeh, et al.
Publicado: (2019)

Epithelial Transcription Factor FOXA1 Regulates Prostate Cancer Immune Response
por: Brea, Lourdes T, et al.
Publicado: (2021)

MON-317 Ectopic Cushing's Syndrome Due to Prostate Cancer: A Case Series
por: Kanbour, Sarah, et al.
Publicado: (2019)

SAT-329 Novel Dehydroepiandrosterone Derivatives Inhibiting Metastatic Prostate Cancer Cell Proliferation
por: Cabeza, Marisa, et al.
Publicado: (2019)

Prostatic Acid Phosphatase Is a Progenitor Cell Marker That Persists After Androgen Ablation
por: Izadmehr, Sudeh, et al.
Publicado: (2021)

RF19 | PSUN344 Control of Androgen Signaling and Metastasis by CARF in Prostate Cancer
por: Hasan, Kamrul, et al.
Publicado: (2022)

Preclinical Evidence of the Efficacy of Lewis Y Car T Cells in Patient-Derived Models of Prostate Cancer
por: Risbridger, Gail Petuna, et al.
Publicado: (2021)

THU476 Role Of Mitochondrial Sirtuins 3 And 5 On Glutamine Addiction In Prostate Cancer Cell
por: Hasan, Kamrul M, et al.
Publicado: (2023)

SUN-139 Luminescence-Based Drug Screen for Novel Androgen Receptor Antagonists for Prostate Cancer Therapy
por: Azur, Romie Angelo G, et al.
Publicado: (2020)

SAT-LB306 A Case of Synchronous Non-Functioning Paraganglioma of the Urinary Bladder and Prostate Cancer
por: Choi, Moon Kyung, et al.
Publicado: (2020)

SAT-138 Neutrophil Elastase Promotes Proliferative Signals in Prostate Cells Through EGFR and DDR1
por: Xiao, Zhiguang, et al.
Publicado: (2020)

THU479 FOXA1 Loss Remodels The Tumor Immune Microenvironment In Late-stage Prostate Cancer
por: Brea, Lourdes T, et al.
Publicado: (2023)

Prostate Cancer Stimulation by a Novel Liver X Receptor (LXRa)-Estrogen Related Receptor (ERRa) Axis
por: Song, Chung Seog, et al.
Publicado: (2021)

THU528 ACTH-dependent Hypercortisolism From Neuroendocrine Prostate Tumor With Negative ACTH Staining Of The Tumor Cells
por: Fariduddin, Maria, et al.
Publicado: (2023)

THU502 CYR61, A Member Of The CCN Protein Family, Regulates IGF1 In Metastatic Prostate Cancer
por: Ortiz Hernandez, Greisha L, et al.
Publicado: (2023)

SAT-327 Targeting FOXA1-mediated Repression of TGF-B Signaling Supresses Castration-Resistant Prostate Cancer Progression
por: Park, Su Hong (Kevin)
Publicado: (2019)

SAT-114 Loss of DHEA-Targeting SULT2b1b Sulfotransferase Exacerbates Aggressive Traits of Prostate Cancer
por: Song, Chung Seog, et al.
Publicado: (2020)

SAT-132 The Secretory Vesicle Membrane Protein, CYB561, Promotes the Growth and Metastatic Potential of Castration-Resistant Neuroendocrine Prostate Cancer
por: Olarte, Kevin Christian V, et al.
Publicado: (2020)

THU550 The Splicing Factor SRSF6 Regulates Androgen Receptor Activity And Represents A Potential Therapeutic Target In Prostate Cancer
por: Luque, Raul M, et al.
Publicado: (2023)

RF05 | PSUN358 ANPEP: A potential regulator of tumor cell - macrophage metabolic interactions in prostate cancer of African American men
por: Yamoah, Kosj, et al.
Publicado: (2022)

OR05-05 A Novel Model Of Prostate Cancer Suggests Enzalutamide Functions Through The Immune System To Diminish Castration Resistant And Metastatic Growth
por: Kregel, Steven
Publicado: (2023)

RF07 | PSAT233 The First Case Report of a de-novo Purely Prostatic Large Cell Neuroendocrine Carcinoma with Thyroid and Adrenal Metastases
por: Paparodis, Rodis, et al.
Publicado: (2022)

Osteoblast-Induced Prostate Cancer Cell Migration and Invasion Is Mediated Through TGF-β1/SMAD2 Signal Pathway and Blocked by 17α-Estradiol
por: Shi, Jian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ibg1ptn3bv39237a6asvn0d87n